Bexion Pharmaceuticals Announces the Opening of Phase I Part 3 First-in-Human Trial Using BXQ-350 for the Treatment of Cancer Beth Kaiser2022-09-01T20:18:31-04:00February 22, 2019|
CTI to relocate to Covington, bring $36.4M investment, 500 jobs Beth Kaiser2023-04-20T12:43:34-04:00August 17, 2016|